Fritextsökning
Innehållstyper
-
Hey Johannes Hedman...
... graduate of SKL and LTH, who has improved a method of forensic analysis
-
Schizophrenia and bipolar disorder are relatives
Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.
-
Safe and economic dispensing of powders
Mettler Toledo is showcasing Quantos, an automated dispenser for laboratory use.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Danish discovery could help cardiac patients
The Danish researchers have developed a component that could make live easier forpatients with heart failure.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Biogaia's advance goes on
In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.
-
Will the industry follow the economic revival?
Welcome to the eleventh Biotech Forum + Scanlab Fair!
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Rapid and thorough homogenization of samples
MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.
-
Fortsatt högtryck i svensk export
Fortsatt positiv syn på exporten bland svenska företag visar Business Swedens färska siffror.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Pfizer drar tillbaka artiklar
Utredning visar att sex artiklar om onkologi från läkemedelsjätten Pfizer innehåller förfalskade data. En av personerna bakom forskningen har lämnat bolaget.
-
Danish biorefinery can save US billions
The Danish Inbicon biorefinery process could save the US billions on foreign oil, the organization states.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Årets Salss handlar om hjärnan
Årets toppmöte för företagare, världsledande forskare och läkare samlas nu för ett tre dagars konvent i Stockholm. Arrangören Barbro Ehnbom har ett tydligt mål ...
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
BREAKING